APOB and urinary bladder cancer: The experiments provide a new insight into the efficacy of novel antimicrobial strategy, i.e., an antimicrobial peptide identified in human apolipoprotein B, alone or in combination with antibiotics, in fighting clinically isolated bacteria from bladder cancer patients after radical cystectomy.